L-NAME is a widely used NO synthase inhibitor, and chronic treatment with L-NAME is known to decrease NO bioavailability and imbalance the excretion of other vascular tone regulators, such as Ang II and ET-1, leading to hypertension [15]. The gene discussed is EDN1; the disease is hypertensive disorder.